188 related articles for article (PubMed ID: 35978257)
1. Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy).
Bezzini D; Gualdani E; Razzanelli M; Battaglia MA; Cortese R; Francesconi P; Ulivelli M
Neurol Sci; 2022 Nov; 43(11):6407-6414. PubMed ID: 35978257
[TBL] [Abstract][Full Text] [Related]
2. Chronic diseases and comorbidities in adults with and without intellectual disabilities: comparative cross-sectional study in Dutch general practice.
van den Bemd M; Schalk BWM; Bischoff EWMA; Cuypers M; Leusink GL
Fam Pract; 2022 Nov; 39(6):1056-1062. PubMed ID: 35579254
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
Marck CH; Neate SL; Taylor KL; Weiland TJ; Jelinek GA
PLoS One; 2016; 11(2):e0148573. PubMed ID: 26849357
[TBL] [Abstract][Full Text] [Related]
4. Common Comorbidities of Stroke in the Canadian Population.
Elamy AH; Shuaib A; Carriere KC; Jeerakathil T
Can J Neurol Sci; 2020 May; 47(3):314-319. PubMed ID: 31955718
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.
López Varela MV; Montes de Oca M; Halbert R; Muiño A; Tálamo C; Pérez-Padilla R; Jardim JR; Valdivia G; Pertuzé J; Menezes AM;
Arch Bronconeumol; 2013 Nov; 49(11):468-74. PubMed ID: 23856439
[TBL] [Abstract][Full Text] [Related]
6. Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey.
Gini R; Francesconi P; Mazzaglia G; Cricelli I; Pasqua A; Gallina P; Brugaletta S; Donato D; Donatini A; Marini A; Zocchetti C; Cricelli C; Damiani G; Bellentani M; Sturkenboom MC; Schuemie MJ
BMC Public Health; 2013 Jan; 13():15. PubMed ID: 23297821
[TBL] [Abstract][Full Text] [Related]
7. Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study.
Palladino R; Marrie RA; Majeed A; Chataway J
Mult Scler; 2023 May; 29(6):671-679. PubMed ID: 37029503
[TBL] [Abstract][Full Text] [Related]
8. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M;
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084
[TBL] [Abstract][Full Text] [Related]
9. [Chronic diseases and risk of symptomatic COVID-19: results of a case-population study on a sample of patients in the Local Health Unit 'Toscana Centro' (Tuscany Region, Central Italy)].
Profili F; Ballo P; Balzi D; Bellini B; Bartalocci S; Zuppiroli A; Voller F; Francesconi P
Epidemiol Prev; 2020; 44(5-6 Suppl 2):308-314. PubMed ID: 33412823
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
11. [Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women].
Rodríguez-Reyes H; Laguna-Muñoz CI; Gallegos-de Luna CF; de-Los-Ríos-Ibarra MO; Salas-Pacheco JL; Leyva-Pons JL; Muñoz-Gutiérrez LM; Vargas-Hernandez A; Rodríguez-Muñoz KM; Barragán-Luna J; Alcocer-Gamba MA; Cortez-Lawrenz J; Farjat-Ruiz J
Arch Cardiol Mex; 2022 Jul; 92(3):349-357. PubMed ID: 34758015
[TBL] [Abstract][Full Text] [Related]
12. Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity.
Neto LO; Ruiz JA; Gromisch ES
Qual Life Res; 2024 Feb; 33(2):573-581. PubMed ID: 37966685
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of comorbidities in patients with multiple sclerosis using administrative data from 2007 to 2016 in Iran.
Amiri Z; Azmin M; Amiri S; Akbarisari A; Sahraian MA; Farzadfar F; Soleymani F
Mult Scler Relat Disord; 2023 Jun; 74():104693. PubMed ID: 37031549
[TBL] [Abstract][Full Text] [Related]
14. A model-based approach to estimating the prevalence of disease combinations in South Africa.
Johnson LF; Kassanjee R; Folb N; Bennett S; Boulle A; Levitt NS; Curran R; Bobrow K; Roomaney RA; Bachmann MO; Fairall LR
BMJ Glob Health; 2024 Feb; 9(2):. PubMed ID: 38388163
[TBL] [Abstract][Full Text] [Related]
15. Obesity in COPD: Comorbidities with Practical Consequences?
Zewari S; Hadi L; van den Elshout F; Dekhuijzen R; Heijdra Y; Vos P
COPD; 2018 Oct; 15(5):464-471. PubMed ID: 30512982
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy).
Coi A; Barsotti S; Santoro M; Almerigogna F; Bargagli E; Caproni M; Emmi G; Frediani B; Guiducci S; Matucci Cerinic M; Mosca M; Parronchi P; Prediletto R; Selvi E; Simonini G; Tavoni AG; ; Bianchi F; Pierini A
Orphanet J Rare Dis; 2021 Feb; 16(1):90. PubMed ID: 33596949
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
[TBL] [Abstract][Full Text] [Related]
18. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
Mult Scler; 2012 Sep; 18(9):1310-9. PubMed ID: 22328682
[TBL] [Abstract][Full Text] [Related]
19. [Comorbidities in COPD].
de Miguel Díez J; García TG; Maestu LP
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.
Cazzola M; Bettoncelli G; Sessa E; Cricelli C; Biscione G
Respiration; 2010; 80(2):112-9. PubMed ID: 20134148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
